The Patent Finder

Dianon Systems, Inc.

Also on record
Records under this name other than patents Dianon Systems, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Dianon Systems, Inc.

PatentTitleStatus Expires Confidence
US 6,171,796Biomarkers and targets for diagnosis prognosis and management of prostate disease
Formerly held
Term ended
Term ended Aug 3, 2019 · From the USPTO record
Term endedTerm ended Aug 3, 2019From the USPTO record
US 6,156,515Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
Formerly held
Term ended
Term ended Feb 9, 2019 · From the USPTO record
Term endedTerm ended Feb 9, 2019From the USPTO record
US 6,218,529Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
Formerly held
Term ended
Term ended Jun 12, 2018 · From the USPTO record
Term endedTerm ended Jun 12, 2018From the USPTO record
US 6,190,857Diagnosis of disease state using MRNA profiles in peripheral leukocytes
Formerly held
Term ended
Term ended Mar 24, 2018 · From the USPTO record
Term endedTerm ended Mar 24, 2018From the USPTO record
US 6,025,128Prediction of prostate cancer progression by analysis of selected predictive parameters
Formerly held
Term ended
Term ended Feb 15, 2017 · From the USPTO record
Term endedTerm ended Feb 15, 2017From the USPTO record
US 7,332,270Diagnosis of disease state using mRNA profiles in peripheral leukocytes
Formerly held
Lapsed on the fee record
Ended Feb 19, 2016 · From the USPTO record
Lapsed on the fee recordEnded Feb 19, 2016From the USPTO record
US 7,993,830Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
Formerly held
Lapsed on the fee record
Ended Aug 9, 2015 · From the USPTO record
Lapsed on the fee recordEnded Aug 9, 2015From the USPTO record
US 6,463,438Neural network for cell image analysis for identification of abnormal cells
Formerly held
Lapsed on the fee record
Ended Oct 8, 2014 · From the USPTO record
Lapsed on the fee recordEnded Oct 8, 2014From the USPTO record
US 6,369,195Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
Formerly held
Lapsed on the fee record
Ended Apr 9, 2014 · From the USPTO record
Lapsed on the fee recordEnded Apr 9, 2014From the USPTO record
US 6,140,065Methods for diagnosing benign prostatic diseases and prostatic adenocarcinoma using an algorithm
Lapsed on the fee record
Ended Oct 31, 2008 · From the USPTO record
Lapsed on the fee recordEnded Oct 31, 2008From the USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited